We can't find the internet
Attempting to reconnect
19310.1 PFLS-LS
19310.1 PFLS-LS
Résumé
Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia
Textes supplémentaires
Abstract
To develop novel peptide drug conjugates that target a newly identified cancer marker overexpressed in multiple cancers. The project aims to create peptide drug conjugates for treating acute myeloid leukemia and obtain at least one drug candidate ready for further development. This will enable Phi Pharma to secure additional financing to prepare for the first clinical trial, and eventually enter into a significant collaboration with a major pharmaceutical company.
Participants
Emmanuel Savioz
Wirtschaftspartner
emmanuel.savioz@phi-pharma.com
Phi Pharma Emmanuel Savioz Place du Midi 36 1950 Sion VS CH
Marc Mathieu
Kontaktperson
marc.mathieu@hevs.ch
HES-SO Valais-Wallis Marc Mathieu Route du Rawyl 64 1950 Sion VS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-09-30
- Date de fin
- 2018-04-30
- Coûts totaux approuvés
- CHF 357830.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%